Prognostic value of integrated dynamic NLR and [(18)F]FDG-PET/CT parameters in resectable non-small cell lung cancer treated with neoadjuvant immunotherapy plus chemotherapy.

Wang S, Yang F, Lu K, Zhu H, Cheng Y, Shao D

Open source

DOI
10.1007/s12149-026-02308-8
Published
2026 Nov 5
Container
Annals of nuclear medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12149-026-02308-8,
  title = {Prognostic value of integrated dynamic NLR and [(18)F]FDG-PET/CT parameters in resectable non-small cell lung cancer treated with neoadjuvant immunotherapy plus chemotherapy.},
  author = {Wang S and Yang F and Lu K and Zhu H and Cheng Y and Shao D},
  year = {2026},
  journal = {Annals of nuclear medicine},
  doi = {10.1007/s12149-026-02308-8},
  url = {https://doi.org/10.1007/s12149-026-02308-8}
}

RIS

TY  - JOUR
TI  - Prognostic value of integrated dynamic NLR and [(18)F]FDG-PET/CT parameters in resectable non-small cell lung cancer treated with neoadjuvant immunotherapy plus chemotherapy.
AU  - Wang S
AU  - Yang F
AU  - Lu K
AU  - Zhu H
AU  - Cheng Y
AU  - Shao D
PY  - 2026
JO  - Annals of nuclear medicine
DO  - 10.1007/s12149-026-02308-8
UR  - https://doi.org/10.1007/s12149-026-02308-8
ER  - 

APA

S, W., F, Y., K, L., H, Z., Y, C., & D, S. (2026). Prognostic value of integrated dynamic NLR and [(18)F]FDG-PET/CT parameters in resectable non-small cell lung cancer treated with neoadjuvant immunotherapy plus chemotherapy.. Annals of nuclear medicine. https://doi.org/10.1007/s12149-026-02308-8

Source records